Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- 2015 Spartan Challenge entrepreneurship competition offers more than $20,000 in prizes
- School of Medicine Dean Davis, Assistant Professor Justin Lathia recognized at Ohio Cancer Research Associates event
- Engineering’s Timothy Peshek one of 10 in the world to receive funding through Google’s Little Box Challenge
- Engineering PhD student wins best student paper award at international event
- 5 questions with…swimmer, school record-holder Drew Hamilton